Search research articles
Contact Us
Filters
Showing results (81-90 of 200) with videos related to
Page
of 20
Sort By:
American Journal of Clinical Oncology
|
December 1, 1989
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer
P Pronzato, E Campora, D Amoroso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2012
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis
M V Dieci, E Barbieri, F Piacentini, et al.
Breast Cancer Research and Treatment
|
November 1, 1990
Megestrol acetate: phase II study of a single daily administration in advanced breast cancer
P Pronzato, F Brema, D Amoroso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma
A Alama, F Merlo, S Chiara, et al.
Anticancer Research
|
February 24, 2001
p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen
A Gadducci, C Cianci, S Cosio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1996
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaks
M Andreuccetti, G Allegrini, A Antonuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 10, 2013
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients
V Guarneri, M V Dieci, E Barbieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients
A Falcone, R Danesi, F Dargenio, et al.
European Journal of Clinical Pharmacology
|
February 27, 2003
Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case report
G Bocci, R Danesi, G Allegrini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer
A Alama, S Chiara, F Merlo, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 200) with videos related to
Sort By:
Page
of 20
American Journal of Clinical Oncology
|
December 1, 1989
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer
P Pronzato, E Campora, D Amoroso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2012
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis
M V Dieci, E Barbieri, F Piacentini, et al.
Breast Cancer Research and Treatment
|
November 1, 1990
Megestrol acetate: phase II study of a single daily administration in advanced breast cancer
P Pronzato, F Brema, D Amoroso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma
A Alama, F Merlo, S Chiara, et al.
Anticancer Research
|
February 24, 2001
p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen
A Gadducci, C Cianci, S Cosio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1996
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaks
M Andreuccetti, G Allegrini, A Antonuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 10, 2013
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients
V Guarneri, M V Dieci, E Barbieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients
A Falcone, R Danesi, F Dargenio, et al.
European Journal of Clinical Pharmacology
|
February 27, 2003
Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case report
G Bocci, R Danesi, G Allegrini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer
A Alama, S Chiara, F Merlo, et al.
Page
of 20